AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study
Journal article
Meeraus W. et al, (2024), Journal of Infection, 88
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Journal article
Hayward G. et al, (2024), Journal of Infection, 88
Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized Trials.
Journal article
Shah SJ. et al, (2024), Circ Cardiovasc Qual Outcomes
Safety, Efficacy and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Treatment of Mild-to-Moderate COVID-19: 15-Month Final Analysis of the TACKLE Trial.
Journal article
Hobbs FDR. et al, (2024), Infect Dis Ther, 13, 521 - 533
The feasibility of population screening for paroxysmal atrial fibrillation using handheld ECGs.
Journal article
Mant J. et al, (2024), Europace
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Journal article
Standing JF. et al, (2024), Nature communications, 15
Risk of severe COVID-19 outcomes after autumn 2022 COVID-19 booster vaccinations: a pooled analysis of national prospective cohort studies involving 7.4 million adults in England, Northern Ireland, Scotland and Wales
Journal article
Bedston S. et al, (2024), The Lancet Regional Health - Europe, 37
Disparities in COVID-19 Mortality Amongst the Immunosuppressed: A Systematic Review and Meta-analysis for Enhanced Disease Surveillance.
Journal article
Leston M. et al, (2024), J Infect
Cost-utility analysis of molnupiravir plus usual care versus usual care alone as early treatment for community-based adults with COVID-19 and increased risk of adverse outcomes in the UK PANORAMIC trial.
Journal article
Png ME. et al, (2024), Br J Gen Pract
Protocol for an e-Delphi study to achieve consensus on a definitive adult immunosuppressed phenotype (Preprint)
Preprint
Leston M. et al, (2024)
Diagnostic accuracy of a point-of-care antigen test for SARS-CoV-2 and influenza in a primary care population (RAPTOR-C19)
Journal article
Fanshawe TR. et al, (2024), Clinical Microbiology and Infection
Lessons from the English primary care sentinel network's response to the COVID-19 pandemic
Journal article
de Lusignan S. et al, (2024), The Lancet Infectious Diseases, 24, 14 - 16
Correction: Development and evaluation of rapid data-enabled access to routine clinical information to enhance early recruitment to the national clinical platform trial of COVID-19 community treatments (Trials, (2022), 23, 1, (62), 10.1186/s13063-021-05965-4)
Journal article
Cake C. et al, (2023), Trials, 24
Informed consent in randomised controlled trials: further development and evaluation of the participatory and informed consent (PIC) measure
Journal article
Wade J. et al, (2023), Trials, 24
A targeted approach to vaccine hesitancy
Journal article
Leston M. et al, (2023), Oxford Open Immunology
COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study
Journal article
Whitaker HJ. et al, (2023), Journal of Infection, 87, 315 - 327
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials
Journal article
Barco S. et al, (2023), Thrombosis Research, 230, 27 - 32
The drivers of non-adherence to albuminuria testing guidelines and the clinical and economic impact of not identifying chronic kidney disease.
Journal article
Groehl F. et al, (2023), Clin Nephrol, 100, 145 - 156
Platform adaptive trial of novel antivirals for early treatment of COVID-19 in the community (PANORAMIC): Protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
Journal article
Gbinigie O. et al, (2023), BMJ Open, 13
Predicting the risk of acute kidney injury in primary care:
Journal article
Koshiaris C. et al, (2023), British Journal of General Practice, 73, E605 - E614